CD8A and neoplasm: Although in vivo treatment of tumour-bearing mice with DEG reduces tumour growth, while increasing the quantity of both circulating and tumour-infiltrating CD8+ T cells, the CD8+ phenotypic changes observed with ex vivo treatment with DEG were not observed in tumour-infiltrating CD8+ T cells.